The joy of getting out of your own wayI now dare to dream that we are on the brink of initiating our own change. Is it okay to use type 2 diabetes medications in people with type 1 diabetes?Recently, I was approached by a colleague who had seen a patient with type 1 diabetes using a glucagon-like peptide-1 receptor agonist in combination with basal bolus insulin to manage their glucose levels. The cost of defensive med Why psychological safety matters in physician regulation. Problem solved: How do I make my EMR work for me? We asked, your colleagues answered! See what they had to say about making sure your EMR is making your life easier. Editorial: With OTCs, I don’t know what I don’t know Each year in our Survey on OTC Counselling and Recommendations, we ask pharmacists to share their insights about helping patients select nonprescription products. Managing patient misinformation Misinformation limits access to care, wastes resources, and increases stress for both patients and pharmacists. The virtual standard: Navigating the medico-legal landscape of virtual care Has the new abundance of virtual care changed the number of complaints and lawsuits? The real housing decision: Roots vs. wings Why the ‘renting is throwing money away’ narrative fails the math test. Timing is everything In a tragic RSV case, a judge found only one of three physicians liable. Five osteoporosis pearls: Clinical tips for treating men and women ‘The promise of a drug holiday may actually inspire patients to take their bisphosphonate.’ 1 2 3 4 5 Next Last
